A Phase I Study of Hypofractionated Stereotactic Radiotherapy and Concurrent HIV Protease Inhibitor Nelfinavir as part of a Neoadjuvant Regimen in Patients with Locally Advanced Pancreatic Cancer

被引:0
|
作者
Lin, C. [1 ]
Sasson, A. R. [1 ]
Ly, Q. P. [1 ]
Kos, M. E. [1 ]
Schwarz, J. K. [1 ]
Are, C. [1 ]
Chen, S. [1 ]
Sehi, E. D. [1 ]
Enke, C. A. [1 ]
Grem, J. L. [1 ]
机构
[1] Univ Nebraska Med Ctr, Omaha, NE USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词
D O I
10.1016/j.ijrobp.2011.06.136
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S68 / S68
页数:1
相关论文
共 50 条
  • [21] Concurrent radiotherapy with capecitabine and weekly irinotecan as neoadjuvant treatment for locally advanced rectal cancer: a phase I/II study
    Klautke, Gunther
    Feyerherd, Peter
    Ludwig, Kaja
    Foitzik, Thomas
    Klar, Ernst
    Fietkau, Rainer
    ANNALS OF ONCOLOGY, 2004, 15 : 80 - 80
  • [22] Survival Outcome of a Phase 1 Trial: Hypofractionated Stereotactic Body Radiation Therapy Concurrent With Nelfinavir Following Gemcitabine and 5FU in Patients With Locally Advanced Pancreatic Adenocarcinoma
    Lin, C.
    Sasson, A. R.
    Ly, Q. P.
    Schwarz, J. K.
    Are, C.
    Kos, B. M.
    Lazenby, A. J.
    Ketcham, M. A.
    Sehi, E. D.
    Grem, J. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S203 - S203
  • [23] A Phase II Study of Concurrent Docetaxel, Epirubicin and Cyclophosphamide as a Neoadjuvant Chemotherapy Regimen in Patients with Locally Advanced Breast Cancer
    Yao, Xin
    Hosenpud, Janet
    Chitambar, Christopher R.
    Charlson, John
    Cheng, Yee Chung
    JOURNAL OF CANCER, 2012, 3 : 145 - 151
  • [24] Stereotactic radiotherapy after chemotherapy in patients with locally advanced pancreatic cancer
    LE ROY, C.
    Barbe, R.
    Sun, R.
    Burtin, P.
    Gelli, M.
    Deutsch, E.
    Durand-Labrunie, J.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1089 - S1089
  • [25] Dose escalation of Stereotactic Body Radiotherapy (SBRT) for locally advanced unresectable pancreatic cancer patients with CyberKnife: protocol of a phase I study
    Qing, Shui-Wang
    Ju, Xiao-Ping
    Cao, Yang-Sen
    Zhang, Huo-Jun
    RADIATION ONCOLOGY, 2017, 12
  • [26] Dose escalation of Stereotactic Body Radiotherapy (SBRT) for locally advanced unresectable pancreatic cancer patients with CyberKnife: protocol of a phase I study
    Shui-Wang Qing
    Xiao-Ping Ju
    Yang-Sen Cao
    Huo-Jun Zhang
    Radiation Oncology, 12
  • [27] A phase I study of hypofractionated radiotherapy followed by systemic chemotherapy with full-dose gemcitabine in patients with unresectable locally advanced pancreatic cancer
    Furuse, Junji
    Ishii, Hiroshi
    Kawashima, Mitsuhiko
    Nagase, Michitaka
    Nihei, Keiji
    Nakachi, Kohei
    Ogino, Takashi
    Yoshino, Masahiro
    HEPATO-GASTROENTEROLOGY, 2007, 54 (77) : 1575 - 1578
  • [28] A Phase 1 Study of Gemcitabine and S-1 Concurrent Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
    Matsumura, Yuji
    Suyama, Masafumi
    Sai, Jinkan
    Kubokawa, Yoshihiro
    Kamiya, Takayoshi
    Watanabe, Sumio
    PANCREAS, 2011, 40 (05) : 799 - 800
  • [29] Phase I/II study of gemcitabine plus S-1 with concurrent radiotherapy in patients of unresectable locally advanced pancreatic cancer
    Ioka, Tatsuya
    Katayama, Kazuhiro
    Ishida, Nobuko
    Sueyoshi, Hironari
    Takada, Ryoji
    Yamai, Takuo
    Fukutake, Nobuyasu
    Ashida, Reiko
    Akita, Hirofumi
    Takahashi, Hidenori
    Kawaguchi, Yoshifumi
    Konishi, Koji
    Teshima, Teruki
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [30] Phase I study of conformal radiotherapy with concurrent gemcitabine in locally advanced bladder cancer
    Sangar, VK
    McBain, CA
    Lyons, J
    Ramani, VAC
    Logue, JP
    Wylie, JP
    Clarke, NW
    Cowan, RA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (02): : 420 - 425